Evidence map›Paper›PMID 40355715›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

A new classification scheme for laryngomalacia.

H Attya

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

H AttyaCairo University, Faculty of Medicine, ENT Department, Cairo University Children's Hospital, Al Inshaa WA Al Munirah, El Sayeda Zeinab, Cairo Governorate, 11617, Egypt. hesham_anwar@cu.edu.eg.ORCID http://orcid.org/0000-0002-7175-8666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo propose a novel classification method for assessing the severity of laryngomalacia (LM). MATERIALS AND

methodsDuring a three-year period, all paediatric patients diagnosed with laryngomalacia were included. A disease-specific questionnaire consisting of eleven questions with four possible responses was administered to gather patient information, and a scoring system was utilized to classify the severity of their condition based on medical history and examination findings. Patients were assigned to two groups: group 1 included those having LM with no or mild co morbidities, group 2 included patients with severe co morbidities. Group 1 was further subdivided into three subgroups based on symptom scores [ (1a) with a score of 1-11, (1b) with a score of 12-22, and (1c) with a score of 23-33].

resultsThe study enrolled a total of fifty participants. Five individuals with laryngomalacia and severe comorbidities were placed in group 2, while the remaining forty-five participants were assigned to group 1. Initial assessment revealed that thirty-five participants were categorized in subgroup 1c and 10 in subgroup 1b. Individuals in subgroup 1c underwent supraglottoplasty and demonstrated an average 25% reduction in symptom scores at 6 weeks post-surgery.

conclusionA severity-based classification system is proposed, and a management strategy is presented for laryngomalacia.

Indexed as

LaryngomalaciaChildChild, PreschoolFemaleHumansInfantMaleSeverity of Illness IndexSurveys and QuestionnairesClassificationLaryngomalaciaSeverity

Identifiers

PMID40355715
PMCPMC12321643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.